Quantib Prostate

by Quantib BV  · Based in Netherlands → — Advanced AI to accelerate the interpretation of multi-parametric MRI for prostate cancer diagnosis.
Radiology Urology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Quantib Prostate is a state-of-the-art AI-based software solution designed to enhance and streamline the MRI prostate reporting workflow for radiologists and urologists. It leverages advanced artificial intelligence technologies to analyze MR images used for prostate cancer diagnosis, providing accurate, fast, and reliable results. The software integrates core reading tasks into a single workflow, eliminating the need to switch between multiple tools for calculations or reporting.

Key functionalities include AI-based segmentations and volumetry of the prostate and its sub-regions, automatic calculation of PSA density, and precise registration and movement correction. It offers one-click segmentation of lesion candidates and AI-supported Region of Interest (ROI) segmentation, facilitating faster and more efficient assessment of potential abnormalities. The system also provides visual PI-RADS scoring support (v.2.1) and generates comprehensive, standardized reports that include key images and a clear visual representation of scoring results.

Quantib Prostate is an FDA-cleared and CE-marked solution, ensuring regulatory compliance across major markets. It is deployable both on-premises and via the cloud, offering a seamless and scalable workflow. The software aims to manage the increasing volume of prostate MRIs, reduce manual review time, and improve diagnostic confidence and efficiency for healthcare professionals.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based prostate and sub-region segmentation and volumetry
  • Automatic PSA density calculation
  • Precise registration and movement correction
  • One-click segmentation of lesion candidates (ROIs)
  • Visual PI-RADS v.2.1 scoring support
  • Standardized reporting with key images
  • Bi-parametric heat map representation of suspicious areas
  • Kinetic curve representation per ROI and for the entire prostate gland
  • Export of segmentations and reports to PACS and compatible systems
  • Zero-footprint software deployment

Use Cases

  • Accelerating interpretation of multi-parametric MRI for prostate cancer
  • Enhancing prostate cancer detection and diagnosis
  • Streamlining prostate MRI reading workflow for radiologists
  • Improving diagnostic quality and speed for radiologists and urologists
  • Supporting PI-RADS scoring and standardized reporting
  • Facilitating MRI-targeted biopsies through integration with compatible systems

What Physicians Need to Know

Key Capabilities
AI-based automatic segmentation of the prostate gland and sub-regions, calculation of PSA density, precise MRI image registration and movement correction, bi-parametric heat maps to highlight suspicious areas, one-click lesion segmentation, and visual PI-RADS scoring support. It also generates standardized reports and provides kinetic curve representation per ROI.
Clinical Utility
Enhances diagnostic accuracy and efficiency, particularly for inexperienced radiologists, by improving sensitivity and positive predictive value for clinically significant prostate cancer (csPCa) detection. It reduces inter-reader variability and helps manage the increasing workload of prostate MRIs. The tool is especially sensitive for high-risk patients.
Integration Options
Exports prostate gland segmentation, ROIs, and standardized reports to PACS and compatible systems. It is compatible with leading fusion biopsy systems (e.g., Focal Healthcare's Fusion Bx) and is deployed through the Quantib AI Node platform for seamless workflow integration.
Compliance Status
FDA cleared (versions 1.3, 2.0, 3.0) and CE marked (Class IIb). Designed in compliance with US recognized consensus standards including ANSI AAMI ISO 14971, ANSI AAMI IEC 62304, and ANSI AAMI IEC 62366-1.
Pricing Model
Custom pricing model, which varies based on the specific features required and the size and needs of the organization. No fixed starting price is publicly disclosed.
User Experience
Offers an intuitive and comprehensive workflow, aiming to improve reporting quality and speed. It is described as a 'zero-footprint software' enabling real-time workflows. Newer versions include improved segmentation algorithms and automated lesion drawing to enhance user experience.
Support Quality
Information indicates availability of email/help desk, phone support, and a knowledge base. However, one source also notes a 'lack of support options' as a potential con.
Implementation Complexity
Offers a seamless and scalable workflow, with deployment options both on-premises and via the cloud. It is deployed through the Quantib AI Node platform, which facilitates rapid regulatory clearance. Certain acquisition criteria and scan setting requirements apply.
Evidence Base
Supported by studies demonstrating increased diagnostic performance (sensitivity, PPV) for AI-assisted radiologists, particularly for less experienced readers and in high-risk patients. Clinical performance for semi-automatic prostate segmentation has been tested, and the solution is backed by trials like PROMISS and Precision. Clinical trials are registered (e.g., NCT06298305).
Physician Tip

Quantib Prostate serves as a valuable supportive tool, especially for less experienced radiologists, by enhancing diagnostic accuracy and streamlining the prostate MRI reading workflow. While it can significantly improve sensitivity in detecting clinically significant prostate cancer and reduce inter-reader variability, it should be used as an aid to interpretation rather than a standalone diagnostic. Physicians should be aware of its specific utility in high-risk patients and leverage its standardized reporting features for consistent communication. It can help optimize workload given the increasing demand for prostate mpMRI.

Quantib Prostate is designed for seamless integration into existing radiology workflows, primarily through its ability to export data (segmentations, ROIs, standardized reports) to PACS and other compatible systems. It also boasts compatibility with leading fusion biopsy systems, which is crucial for MRI-targeted biopsies. However, public information regarding broader third-party integrations is limited, and the platform does not currently offer API coverage.

Details

Category Oncology AI
Pricing Contact for pricing
  • The starting price of the platform varies according to the Quantib Prostate features required by an organization
  • Get a personalized Quantib Prostate pricing plan based on your company's requirements
DeploymentOn-premises and cloud-based (via Quantib AI Node platform)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Quantib Prostate 3.0 received FDA 510(k) clearance (K230772) on April 17, 2023, for its AI-based software solution that advances MRI prostate reporting workflow and its output for radiologists and urologists.
Integrations
EHR Not specified
Specialties Radiology, Urology

What the Web Says

Quantib Prostate is an AI-powered software designed to assist radiologists and urologists in diagnosing and treating prostate conditions by analyzing MRI data. It aims to improve diagnostic accuracy, enhance workflow efficiency, and support clinical decision-making. The software has received FDA clearance and CE marking, indicating regulatory compliance.

Overall: Positive

Strengths

  • Enhances diagnostic accuracy, especially for inexperienced radiologists.
  • Improves workflow efficiency by integrating core reading tasks and automating segmentation.
  • Provides actionable insights through cutting-edge algorithms for lesion detection and quantification.
  • Offers an intuitive interface for navigating patient data, reviewing findings, and generating reports.
  • Reduces inter-reader variability and provides expert-level diagnostic support for complex cases.
  • Supports clinical research by providing data for studies on prostate health and treatment outcomes.

Limitations

  • Limited advanced customization options.
  • Occasional lag in updates or syncing.
  • Does not significantly improve detection rates for experienced radiologists.
  • Limited mobile accessibility.
  • Lack of support options and no API coverage mentioned in one review.
  • Diagnosis should not be made solely based on the analysis performed using Quantib Prostate.

Based on reviews from: SoftwareWorld, Codatis, Software Finder, DeepHealth - Health AI Register, Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study - PMC, RadNet, The Added Value of Artificial Intelligence Using Quantib Prostate for the Detection of Prostate Cancer at Multiparametric Magnetic Resonance Imaging - Beyond the Abstract - UroToday, The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging - PubMed, Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study - MDPI, Prostate MRI PI-RADS Scoring by the Machine Learning Software Quantibu00ae Prostate: A Retrospective Agreement Pilot Study - MDPI, Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study - Semantic Scholar, Integration of magnetic resonance imaging and deep learning for prostate cancer detection: a systematic review - e-Century Publishing Corporation, My Prostate MRI Result, Please Help Me Understand what I have. - Reddit, FDA Clears DeepHealth and Quantib Mammography and Prostate AI Tools, AI segmentation for clinical purposes : r/Neuroradiology - Reddit

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Quantib Prostate

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Quantib
Quantibu00ae Prostate Now Integrates with Focal Healthcare's Fusion Bx
Quantibu00ae Prostate, an FDA cleared and CE marked AI-based software, now integrates with Focal Healthcare's Fusion Bx to streamline prostate MRI reading and make MRI-targeted biopsies more accessible. This integration aims to manage the growing workload of radiologists and improve patient outcomes.
2023-01
RadNet
RadNet's Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostateu2122 3.0 Software
RadNet announced FDA clearance for the third-generation release of its Quantib Prostateu2122 3.0 MRI artificial intelligence (AI) software, enhancing prostate MRI reporting workflow with improved algorithms and tools. This update aims to support radiologists and urologists with faster and more accurate diagnoses.
2023-05
Diagnostic Imaging
FDA Clears RadNet's Updated AI Software for Prostate MRI
The FDA granted 510(k) clearance to Quantib Prostate 3.0 (RadNet), an AI-based software designed to enhance radiology workflow and interpretation of prostate MRI. Key features include an improved algorithm for prostate and subregion segmentation and automated lesion drawing on the PI-RADS sector map.
2023-05
PubMed (Tomography)
Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study
This study evaluated the clinical utility of Quantib Prostate AI software for prostate cancer lesion detection on multiparametric MRI, comparing an expert radiologist with an inexperienced radiologist aided by the software. The results suggest that Quantib Prostate can be a very accurate tool for initial PCa diagnosis and a supporting tool for untrained radiologists.
2022-08
Imaging Technology News (ITN)
FDA Clears DeepHealth and Quantib Mammography and Prostate AI Tools
RadNet Inc. announced FDA clearances for its DeepHealth Saige-DX mammography and Quantib Prostate 2.0 MRI artificial intelligence (AI) algorithms. The Quantib Prostate 2.0 update includes fully automatic prostate zone segmentation and automated initiation of lesion localization on the PI-RADS sector map.
2022-05
AuntMinnieEurope
Quantib secures CE Mark for prostate MRI software
AI software developer Quantib secured the CE Mark for its Quantib Prostate package for prostate MRI interpretation, featuring tools like image-based PSA density calculation and a biparametric heat map. This clearance allows for its use in Europe.
2021-04
Quantib
Quantib Receives FDA Clearance for First-to-Market Prostate Solution
Quantib announced FDA clearance for its prostate solution, a zero-footprint software providing a comprehensive and intuitive workflow for enhanced assessments in prostate MRI. This marked the first time a comprehensive AI prostate solution was available to radiologists in the United States.
2020-10
PubMed (La Radiologia Medica)
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging
This study evaluated the diagnostic performance of radiologists with varying experience using Quantib Prostate for prostate cancer detection on mpMRI. While it did not enhance detection for experienced readers, the AI-based software improved performance for inexperienced readers.
2025-05

Videos

Product demos, reviews, and walkthroughs for Quantib Prostate.

View all on YouTube

Frequently Asked Questions

Quantib Prostate seamlessly integrates into existing radiology workflows by connecting with PACS and compatible systems, automating tasks like prostate and sub-region segmentation, PSA density calculation, and PI-RADS scoring support. This streamlines the prostate MRI reading process, helping radiologists manage increased workloads and facilitating standardized reporting for diagnosis, treatment planning, and even fusion biopsy procedures.
Quantib Prostate has received FDA clearance in the U.S. for multiple versions, including 3.0, and holds a Class IIb CE Mark in Europe. As a medical device, its development and deployment through platforms like the Quantib AI Node are designed to adhere to relevant regulatory standards, which typically encompass data security and privacy considerations, though specific HIPAA or GDPR mechanisms are not detailed in public information.
Quantib Prostate differentiates itself by providing AI-powered automatic segmentation of the prostate and suspicious regions, automated PSA density calculation, and visual PI-RADS scoring support, which can significantly reduce manual review time and inter-reader variability. It aims to enhance diagnostic accuracy and speed, particularly benefiting less experienced radiologists, and supports the creation of standardized reports for comprehensive communication.
The pricing model for Quantib Prostate is custom and depends on the specific size and needs of an organization. While specific tiers or subscription options are not publicly detailed, the vendor indicates a flexible cost structure, suggesting that practices should contact them directly for a personalized quote.
While Quantib Prostate is a sensitive tool, especially for high-risk patients, studies suggest it may not significantly enhance diagnostic performance for highly experienced radiologists. There is also evidence of potential false positives in certain cases, and methodological heterogeneity in studies can limit generalizability across diverse settings or MRI scanner types.
Quantib Prostate supports clinical decision-making by providing accurate, fast, and reliable analysis of MRI images, including precise segmentations and PI-RADS scoring, which aids in early diagnosis and treatment planning. By standardizing reporting and reducing radiologist workload, it contributes to more consistent and timely patient care, potentially leading to improved outcomes in prostate cancer management.
Quantib is committed to supporting its customers with continuous software improvements and technical assistance. They offer customer support via email and phone, and provide a knowledge base for users. The company, now part of DeepHealth, emphasizes human-centered, intuitive technology to ensure effective implementation and ongoing use by healthcare professionals.

Compare Quantib Prostate

VS
Quantib Prostate vs ProstatID
Oncology AI Direct · 92/100
Quantib Prostate and ProstatID are direct competitors, both being FDA-cleared AI solutions for enhancing prostate cancer diagnosis using MRI. Quantib Prostate focuses on streamlining interpretation with advanced segmentation,…
VS
Quantib Prostate vs QUIBIM Precision Prostate (qp-Prostate)
Oncology AI Direct · 92/100
Both Quantib Prostate and QUIBIM Precision Prostate are FDA-cleared AI solutions designed to enhance prostate MRI interpretation through automated segmentation and PI-RADS compliant reporting. While Quantib Prostate offers…
VS
Quantib Prostate vs QP-Prostate® CAD
Oncology AI Direct · 85/100
Both Quantib Prostate and QP-Prostate® CAD are FDA-cleared AI solutions designed to enhance prostate cancer diagnosis through MRI interpretation, offering core functionalities like prostate segmentation and PI-RADS reporting.…

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Cancer Copilot
Color Health
Oncology AI
Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.
On request
RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

See all Oncology AI tools →

More from Quantib BV

Brain WMH
Quantib BV
Neurology AI
Quantib Brain WMH, now part of DeepHealth's Neuro Suite, is an FDA-cleared AI tool for radiologists, quantifying brain atrophy and white matter hyperintensities on MRI to support the diagnosis and monitoring of neurodegenerative diseases.
Contact for pricing
Quantib Brain
Quantib BV
Neurology AI
Quantib Brain is an AI-powered software for quantitative MRI brain analysis, assisting radiologists and neurologists in detecting and monitoring neurodegenerative changes, brain atrophy, and white matter hyperintensities.
Contact vendor

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.